NO933421L - Konstrastmiddel - Google Patents

Konstrastmiddel

Info

Publication number
NO933421L
NO933421L NO933421A NO933421A NO933421L NO 933421 L NO933421 L NO 933421L NO 933421 A NO933421 A NO 933421A NO 933421 A NO933421 A NO 933421A NO 933421 L NO933421 L NO 933421L
Authority
NO
Norway
Prior art keywords
pct
contrast
atoms
date
sec
Prior art date
Application number
NO933421A
Other languages
English (en)
Other versions
NO933421D0 (no
Inventor
Torsten Almen
Arne Berg
C Allen Chang
Michael Droege
Harald Dugstad
Jere D Fellman
Sook Hui Kim
Jo Klaveness
Scott M Rocklage
Paal Rongved
Brent Segal
Alan D Watson
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919106579A external-priority patent/GB9106579D0/en
Priority claimed from PCT/EP1992/000698 external-priority patent/WO1992017215A1/en
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Publication of NO933421D0 publication Critical patent/NO933421D0/no
Publication of NO933421L publication Critical patent/NO933421L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • C07F11/005—Compounds containing elements of Groups 6 or 16 of the Periodic Table compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/903—Specified use of nanostructure for conversion, containment, or destruction of hazardous material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/928—X-ray agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/929—Ultrasound contrast agent

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Liquid Crystal (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Materials For Medical Uses (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Lubricants (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

Det beskrives et avbildnings-kontrastmiddel som omfatter et fysiologisk akseptabelt multinukleært kompleks (som definert i krav 1). Det multinukleære kompleks inneholder minst 2, men fortrinnsvis 3 eller flere kontrastforbedrende atomer. For røntgen- eller ultralyd-avbildningsteknikker benyttes tungmetallatomer for å forbedre kontrasten mens paramagnetiske metallatomer er kontrastforbedrende ved magnetisk resonansavbildning.olybden og wolfram er fore-trukne kontrastforbedrende atomer. Midlet kan også benyttes terapeutisk.
NO933421A 1991-03-27 1993-09-24 Konstrastmiddel NO933421L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919106579A GB9106579D0 (en) 1991-03-27 1991-03-27 Contrast media
GB919120507A GB9120507D0 (en) 1991-03-27 1991-09-26 Contrast media
PCT/EP1992/000698 WO1992017215A1 (en) 1990-03-28 1992-03-27 Contrast media

Publications (2)

Publication Number Publication Date
NO933421D0 NO933421D0 (no) 1993-09-24
NO933421L true NO933421L (no) 1993-11-24

Family

ID=26298647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933421A NO933421L (no) 1991-03-27 1993-09-24 Konstrastmiddel

Country Status (15)

Country Link
US (2) US5482699A (no)
EP (1) EP0577675B1 (no)
JP (1) JPH06506449A (no)
AT (1) ATE187340T1 (no)
AU (1) AU660013B2 (no)
CA (1) CA2106976A1 (no)
DE (1) DE69230400T2 (no)
ES (1) ES2138970T3 (no)
FI (1) FI934194A (no)
HU (1) HUT65240A (no)
IE (1) IE920996A1 (no)
NO (1) NO933421L (no)
NZ (1) NZ242156A (no)
PH (1) PH29904A (no)
SG (1) SG43930A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019487A1 (fr) * 1994-12-22 1996-06-27 Nissan Chemical Industries, Ltd. Derives d'organobismuth et procede de production
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
DE19507820A1 (de) 1995-02-21 1996-08-22 Schering Ag Neuartig substituierte DTPA-Derivate, deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
US5801228A (en) * 1995-06-07 1998-09-01 Nycomed Imaging As Polymeric contrast agents for medical imaging
US7632651B2 (en) * 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US20050227294A1 (en) * 1997-09-15 2005-10-13 Molecular Devices Corporation Molecular modification assays involving lipids
US7745142B2 (en) * 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US7807137B1 (en) 1998-12-22 2010-10-05 University Of Puerto Rico Iron-based contrast agent
US6596259B1 (en) 1998-12-22 2003-07-22 University Of Puerto Rico Metal based cubane structure contained in an octanuclear complex stable over several oxidation states and a method of producing the same
US20030215391A1 (en) * 2001-07-19 2003-11-20 Carlos Rabito Fluorescent agents for real-time measurement of organ function
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
EP1805188A4 (en) * 2004-09-30 2010-03-03 Mds Analytical Technologies Us COMPLEXES OF LUMINESCENT LANTHANIDES
US7888297B2 (en) * 2005-01-06 2011-02-15 Halliburton Energy Services, Inc. Compositions for reducing the viscosity of treatment fluids
WO2006084382A1 (en) * 2005-02-11 2006-08-17 University Health Network Compositions and methods for multimodal imaging
AU2006266074A1 (en) * 2005-06-30 2007-01-11 Bristol-Myers Squibb Pharma Company Hydrazide conjugates as imaging agents
US20120148501A1 (en) * 2010-12-08 2012-06-14 Fred Geisler Radiological image enhancement with tantalum clusters
JP6032729B2 (ja) * 2012-05-08 2016-11-30 国立研究開発法人理化学研究所 イメージングマーカーおよびその利用
BR112015017818A2 (pt) * 2013-02-06 2017-07-11 Pom Patentverwaltungs Gbr heteropolioxometalatos
CN114573609B (zh) * 2022-03-07 2024-02-06 桂林理工大学 一种基于不对称双核镝配合物的单分子磁体及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE263059C (no) *
DE130934C (no) *
DE361960C (de) * 1920-06-01 1922-10-20 Georg Spiess Rundstapelbogenanleger
US3763188A (en) * 1972-01-19 1973-10-02 Du Pont Spiro(1,1-polyethylenedi(oxymethyl))-3-oxetanes
US3860611A (en) * 1972-01-19 1975-01-14 Du Pont Macrocyclic polyether polyols and condensation polymers derived therefrom
US3952015A (en) * 1973-11-12 1976-04-20 Carl George Krespan Macrocyclic compounds having oxa and aza linkages in the ring and containing spirooxetane groups
US4079124A (en) * 1976-04-21 1978-03-14 Medi-Physics, Inc. Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten
US4176173A (en) * 1977-07-18 1979-11-27 Medi-Physics, Inc. Radiographic compositions
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
US5198208A (en) * 1987-07-16 1993-03-30 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
FR2630547A1 (fr) * 1988-04-22 1989-10-27 Centre Nat Rech Scient Marquage froid de molecules de nature peptidique ou proteique
WO1990003190A1 (en) * 1988-09-29 1990-04-05 Ranney David F Methods and compositions for magnetic resonance imaging
US5213788A (en) * 1988-09-29 1993-05-25 Ranney David F Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
US5260050A (en) * 1988-09-29 1993-11-09 Ranney David F Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
GB9006977D0 (en) * 1990-03-28 1990-05-23 Nycomed As Compositions
GB9007967D0 (en) * 1990-04-09 1990-06-06 Nycomed As Compounds

Also Published As

Publication number Publication date
AU660013B2 (en) 1995-06-08
EP0577675A1 (en) 1994-01-12
DE69230400D1 (de) 2000-01-13
IE920996A1 (en) 1992-10-07
ES2138970T3 (es) 2000-02-01
US5932190A (en) 1999-08-03
SG43930A1 (en) 1997-11-14
FI934194A (fi) 1993-11-23
NZ242156A (en) 1994-07-26
JPH06506449A (ja) 1994-07-21
AU1433892A (en) 1992-11-02
PH29904A (en) 1996-09-16
HU9302735D0 (en) 1993-12-28
EP0577675B1 (en) 1999-12-08
ATE187340T1 (de) 1999-12-15
US5482699A (en) 1996-01-09
FI934194A0 (fi) 1993-09-24
DE69230400T2 (de) 2000-08-03
CA2106976A1 (en) 1992-09-28
NO933421D0 (no) 1993-09-24
HUT65240A (en) 1994-05-02

Similar Documents

Publication Publication Date Title
NO933421L (no) Konstrastmiddel
NO854765L (no) Anvendelse av ferromagnetiske partikler i kontrastmidler for nmr-avbildning og kontrastmidler.
NO980002D0 (no) Kaskadepolymerkomplekser, fremgangsmåte for fremstilling, samt farmasöytiske midler inneholdende disse
LTIP609A (en) Multinuclear complexes, contrast media containing them and use
NO942466D0 (no) Kontrast Media
ES2089245T3 (es) Agentes quelantes.
SE9402880D0 (sv) New peptide derivatives
GB9115375D0 (en) Compounds
AU8950291A (en) Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
YU66199A (sh) Primena intravenoznih kontrastnih sredstava za projekcionu mamografiju
NO972613L (no) Anvendelse av additiver i kontrastmidler for å forbedre avbildning
Seo Recommendations for the Improvement of the Medical Licensing Examination
Nesland Electron Microscopy: Tenth European Congress of Pathology, Athens 1-7 September 1985
NO962831D0 (no) Kontrastmidler for röntgen og magnettomografisk avbildning